These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 16932402)

  • 1. Lactic acidosis in an HIV-infected patient receiving highly active antiretroviral therapy.
    Patel V; Hedayati SS
    Nat Clin Pract Nephrol; 2006 Feb; 2(2):109-14; quiz 115. PubMed ID: 16932402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A high incidence of lactic acidosis and symptomatic hyperlactatemia in women receiving highly active antiretroviral therapy in Soweto, South Africa.
    Bolhaar MG; Karstaedt AS
    Clin Infect Dis; 2007 Jul; 45(2):254-60. PubMed ID: 17578788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of Tris-hydroxymethyl aminomethane in severe lactic acidosis due to highly active antiretroviral therapy: a case report.
    Marfo K; Garala M; Kvetan V; Gasperino J
    J Clin Pharm Ther; 2009 Feb; 34(1):119-23. PubMed ID: 19125910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fatal lactic acidosis associated with highly active antiretroviral therapy in patients with advanced human immunodeficiency virus infection in Taiwan.
    Sheng WH; Hsieh SM; Lee SC; Chen MY; Wang JT; Hung CC; Chang SC
    Int J STD AIDS; 2004 Apr; 15(4):249-53. PubMed ID: 15075019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lactic acidosis in HIV patients receiving highly active antiretroviral therapy.
    Chow YW; Leong CL; Chow HL; Hooi LS
    Med J Malaysia; 2007 Mar; 62(1):78-80. PubMed ID: 17682581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lactic acidosis in HIV-I infected patients receiving antiretroviral therapy.
    Patel AK; Patel K; Patel J
    J Assoc Physicians India; 2004 Aug; 52():666-9. PubMed ID: 15847366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Highly active antiretroviral therapy (HAART)-associated lactic acidosis: in vitro effects of combination of nucleoside analogues and protease inhibitors on mitochondrial function and lactic acid production.
    Nerurkar PV; Pearson L; Frank JE; Yanagihara R; Nerurkar VR
    Cell Mol Biol (Noisy-le-grand); 2003 Dec; 49(8):1205-11. PubMed ID: 14983988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fanconi syndrome and lactic acidosis associated with stavudine and lamivudine therapy.
    Nelson M; Azwa A; Sokwala A; Harania RS; Stebbing J
    AIDS; 2008 Jul; 22(11):1374-6. PubMed ID: 18580619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fatal lactic acidosis and mimicking Guillain-Barré syndrome in an adolescent with human immunodeficiency virus infection.
    Rosso R; Di Biagio A; Ferrazin A; Bassetti M; Ciravegna BW; Bassetti D
    Pediatr Infect Dis J; 2003 Jul; 22(7):668-70. PubMed ID: 12886900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondrial toxicity associated with HAART following liver transplantation in an HIV-infected recipient.
    Antoniades C; Macdonald C; Knisely A; Taylor C; Norris S
    Liver Transpl; 2004 May; 10(5):699-702. PubMed ID: 15108264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Riboflavin treatment of antiretroviral induced lactic acidosis and hepatic steatosis.
    Posteraro AF; Mauriello M; Winter SM
    Conn Med; 2001 Jul; 65(7):387-90. PubMed ID: 11508132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Miller Fisher variant of Guillain-Barré syndrome associated with lactic acidosis and stavudine therapy.
    Shah SS; Rodriguez T; McGowan JP
    Clin Infect Dis; 2003 May; 36(10):e131-3. PubMed ID: 12746793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperlactataemia and lactic acidosis in HIV-infected patients receiving antiretroviral therapy.
    Calza L; Manfredi R; Chiodo F
    Clin Nutr; 2005 Feb; 24(1):5-15. PubMed ID: 15681097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lactacidemia in asymptomatic HIV-infected subjects receiving nucleoside reverse-transcriptase inhibitors.
    Boffito M; Marietti G; Audagnotto S; Raiter R; Di Perri G
    Clin Infect Dis; 2002 Feb; 34(4):558-9. PubMed ID: 11797190
    [No Abstract]   [Full Text] [Related]  

  • 15. [Fatty liver and serum lactate elevation in an HIV patient--is the routine determination of thiamine and riboflavin during HAART useful?].
    Koch HJ
    Dtsch Med Wochenschr; 2003 May; 128(20):1134; author reply 1134. PubMed ID: 12748905
    [No Abstract]   [Full Text] [Related]  

  • 16. Highly active antiretroviral HIV therapy-associated fatal lactic acidosis: quantitative and qualitative mitochondrial DNA lesions with mitochondrial dysfunction in multiple organs.
    Thoden J; Lebrecht D; Venhoff N; Neumann J; Müller K; Walker UA
    AIDS; 2008 May; 22(9):1093-4. PubMed ID: 18520357
    [No Abstract]   [Full Text] [Related]  

  • 17. Lactic acidosis in Africans receiving HAART.
    Kemper CA
    AIDS Alert; 2007 Sep; 22(9):106-8. PubMed ID: 18411465
    [No Abstract]   [Full Text] [Related]  

  • 18. Evidence for mitochondrial toxicity: lactic acidosis as proof of concept.
    Brinkman K
    J HIV Ther; 2001 Mar; 6(1):13-6. PubMed ID: 11501196
    [No Abstract]   [Full Text] [Related]  

  • 19. [Lactic acidosis type B. A life-threatening adverse effect of antiretroviral therapy].
    Justesen US; Pedersen C
    Ugeskr Laeger; 2000 Aug; 162(35):4664-5. PubMed ID: 10986895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fatal lactic acidosis during antiretroviral therapy.
    Rey C; Prieto S; Medina A; Pérez C; Concha A; Menéndez S
    Pediatr Crit Care Med; 2003 Oct; 4(4):485-7. PubMed ID: 14525648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.